Biomarkers of Muscle Anabolism (MK-0000-082)

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Muscle Anabolism
Interventions
DRUG

Comparator: low dose testosterone

Subjects will receive two muscle biopsies, the first at baseline, and the second a week after a single intramuscular dose of 200 mg (0.8 mL) testosterone.

DRUG

Comparator: high dose testosterone

Subjects will receive two muscle biopsies, the first at baseline, and the second a week after a single intramuscular dose of 600 mg (2.4 mL) testosterone.

DRUG

Comparator: placebo

Subjects will receive two muscle biopsies, the first at baseline, and the second a week after a single intramuscular dose of 0.8 mL placebo saline solution.

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00812396 - Biomarkers of Muscle Anabolism (MK-0000-082) | Biotech Hunter | Biotech Hunter